About Yasuda Enterprise Development
Yasuda Enterprise Development is a venture capital firm founded in 1999. It is primarily based out of Chiyoda City, Japan. As of Jun 2013, Yasuda Enterprise Development has invested in 26 companies. It primarily invests in Series C round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Food and Agriculture Tech and High Tech. Most recently it participated in the $***** Series B round of Topica Pharma Overall, Yasuda Enterprise Development portfolio has seen 7 IPOs and 9 acquisitions including key companies like Trevena, Novariant and Enanta. A lot of funds co-invest with Yasuda Enterprise Development, with names like Boston Millennia Partners sharing a substantial percentage of its portfolio. Yasuda Enterprise Development has team of 2 people.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series C, Series A & 4 more
Portfolio IPOs
Portfolio Soonicorns
Yasuda Enterprise Development's List of Top Investments
Yasuda Enterprise Development has a portfolio of 26 companies. Their most notable investments are in Cequent Pharmaceuticals and Trevena.Their portfolio spans across United States, Japan, United Kingdom and 1 more locations. They have invested in Life Sciences, Food and Agriculture Tech, High Tech and 14 other sectors, across stages such as Series C, Series A and 4 more. Here is the list of top investments by Yasuda Enterprise Development:1. Antenova
Antenova provides antennas for wireless M2M, IoT, and consumer electronic devices. Products include RF antenna modules and other various types of antennas that can be classified based on Cellular, GNSS, ISM, LTE, Transfer Jet, WLAN, and other technologies. Has use cases in smart homes, automotive, wearables, healthcare, retail, smart grid, and other areas.
Key facts about Antenova
- Founded Year: 2001
- Location: Hatfield (United Kingdom)
- Annual Revenue: £1M - £10M as on Jul 31, 2013
- Stage: Series C
- Total Funding till date: $37.9M
- Employee Count: 42 as on Mar 31, 2026
- Investors: Invesco, Yasuda Enterprise Development and 11 Others
- Latest Funding Round: Series C, Oct 29, 2008, $*****
- Highlight: Editors' Pick
2. Trevena
Trevena is a developer of GPCR ligand technology-based therapeutics for cardiovascular diseases and pain. It has three programs in development: TRV027, currently in Phase 2 clinical testing for the treatment of acute heart failure; TRV130, currently completing phase 1 testing for the intravenous treatment of postoperative pain; and TRV734, currently in pre-clinical testing for oral treatment of acute and chronic pain. In addition, Trevena has built an early-stage portfolio of drug discovery programs currently in lead optimization.
Key facts about Trevena
- Founded Year: 2007
- Location: Philadelphia (United States)
- Annual Revenue: $1M - $10M as on Dec 31, 2023
- Stage: Public
- Total Funding till date: $119M
- Investors: Polaris Partners, Yasuda Enterprise Development and 6 Others
- Latest Funding Round: Post IPO, Dec 27, 2023, $*****
- Highlight: Public
3. Novariant
Platform focused on autonomous steering systems for agricultural off-highway vehicles. It develops auto-steering and guidance technologies designed to improve precision, efficiency, and control in agricultural machinery operations. The platform supports integration with farming equipment to enable more consistent field operations and reduced operator workload.
Key facts about Novariant
- Founded Year: 1994
- Location: Fremont (United States)
- Stage: Acquired
- Total Funding till date: $60.5M
- Employee Count: 42 as on May 31, 2026
- Investors: Clearstone Venture Partners, Sierra Ventures and 11 Others
- Latest Funding Round: Series D, Dec 22, 2010, $*****
- Highlight: Acquired
4. Enanta
Developer of small molecule drugs for infectious and liver diseases. The lead product of the company is EDP-235, its lead oral coronavirus protease inhibitor specifically designed for the treatment of COVID-19. Also, it develops two protease inhibitors, glecaprevir and paritaprevir for the treatment of respiratory syncytial virus (RSV), hepatitis B virus (HBV), and human metapneumovirus (hMPV).
Key facts about Enanta
- Founded Year: 1998
- Location: Watertown (United States)
- Annual Revenue: $50M - $100M as on Sep 30, 2025
- Stage: Public
- Total Funding till date: $21.2M
- Employee Count: 146 as on May 31, 2026
- Investors: Saints Capital, Industry Ventures and 13 Others
- Latest Funding Round: PE, Sep 03, 2013, $*****
- Highlight: Public
5. Ubiquisys
Ubiquisys is a USA based company which develops small cell system for extending the mobile network coverage.Its product line includes ZoneGate femtocell system which plugs into various broadband connection and provides 3G coverage in the vicinity. the network can also be accessed via mobile devices. It was acquired by Cisco in April 2014.
Key facts about Ubiquisys
- Founded Year: 2004
- Location: Swindon (United Kingdom)
- Stage: Acquired
- Total Funding till date: $81M
- Employee Count: 6 as on May 31, 2026
- Investors: Accel, TriplePoint Capital and 16 Others
- Latest Funding Round: Series C, Aug 15, 2012, $*****
- Highlight: Acquired
Yasuda Enterprise Development's Investments by Stage
Yasuda Enterprise Development is primarily an Late Stage Investor investor majorly investing in Series C (11) rounds where average round size is $254M, Series A (5) rounds where average round size is $32M and Series B (5) rounds where average round size is $126M.Stage of entry | No. of Investments |
|---|---|
Series C | 11 |
Series A | 5 |
Series B | 5 |
Series D | 2 |
PE | 1 |
Others | 1 |
Note: We have considered here, only first round of investments
Yasuda Enterprise Development's Investments by Sector
Yasuda Enterprise Development has a diverse portfolio, with companies operating in the Life Sciences, Sustainability Tech, High Tech, Semiconductors and Consumer. Notably, it has invested in 20 Tech companies, 18 Enterprise (B2B) companies, 5 Tech hardware companies and at least 4 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Life Sciences | 13 |
Sustainability Tech | 5 |
High Tech | 4 |
Semiconductors | 3 |
Consumer | 2 |
Others | 13 |
Note: We have considered here, only first round of investments
Yasuda Enterprise Development's Investments by Geography
Yasuda Enterprise Development has made most investments in United States (17), followed by Japan where it has made 4 investments.Country | No. of Investments |
|---|---|
United States | 17 |
Japan | 4 |
United Kingdom | 2 |
Switzerland | 1 |
Note: We have considered here, only first round of investments
Yasuda Enterprise Development's recent investments
Yasuda Enterprise Development has not made any investment in 2026 so far.Here are the most recent investments by Yasuda Enterprise Development:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jun 10, 2013 | United States | Series B | 1410 | [+1] | |
May 17, 2013 | United States | Series C | 5092 | [+4] | |
Aug 15, 2012 | United Kingdom | Series C | 4768 | ||
Mar 21, 2011 | United States | Series D | 7789 | ||
Jul 14, 2010 | United States | Series B | 7795 | [+3] |
IPOs and Publicly Listed companies in Yasuda Enterprise Development's Portfolio
7 of Yasuda Enterprise Development's portfolio companies have become public. GlobeImmune got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jul 2014 at marketcap of $55.2M and Trevena got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $64.8M.Here are Yasuda Enterprise Development's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jul 02, 2014 | Sep 26, 2007 | Series C | 5658 | |
Jan 31, 2014 | Jul 14, 2010 | Series B | 8443 | |
Mar 22, 2013 | 2004 | PE | 6798 | |
Dec 11, 2012 | Feb 21, 2007 | Series C | 8926 | |
Nov 09, 2005 | Mar 10, 2004 | Series C | 4990 |
Acquired companies in Yasuda Enterprise Development's Portfolio
9 companies from Yasuda Enterprise Development's portfolio have been acquired. The most recent acquisition was Novariant in Oct 2015 by AgJunction for $*****.Here are Yasuda Enterprise Development's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 12, 2015 | May 10, 2005 | Series C | 9787 | |
May 06, 2015 | Oct 22, 2009 | Series C | 4564 | |
Jan 22, 2014 | Sep 04, 2007 | Series D | 7964 | |
Apr 03, 2013 | Jul 12, 2010 | Series C | 8003 | |
Aug 08, 2010 | Jan 15, 2008 | Series C | 7831 |
Team profile of Yasuda Enterprise Development
Yasuda Enterprise Development has a team of 2 members.Co-investors of Yasuda Enterprise Development
Over the past 25 years, 230 investors have co-invested in Yasuda Enterprise Development's portfolio companies. This includes only funds.
- Invested before Yasuda Enterprise Development: New Enterprise Associates, Healthcare Ventures and 49 others have invested in rounds before Yasuda Enterprise Development. There are 2 companies where New Enterprise Associates has invested before Yasuda Enterprise Development and 2 companies where Healthcare Ventures has invested before Yasuda Enterprise Development.
- Top Co-investors of Yasuda Enterprise Development: 107 investors entered a company along with Yasuda Enterprise Development. These include investors like Boston Millennia Partners (3 companies).
- Invested after Yasuda Enterprise Development: A total of 72 investors have invested in Yasuda Enterprise Development's portfolio after their investments. Top Investors include Nippon Venture Capital (2 companies), Mobile Internet Capital (2 companies) and HHS (2 companies).
Recent News related to Yasuda Enterprise Development
•
•
Kovio Raises $15 Million with Lead Investor Tyco Retail SolutionsPR Newswire•Jun 09, 2011•Kovio, DAG Ventures, Northgate Capital, Pangaea Ventures and 11 others
•
•
Synageva Adds $25M in Financing - PE HubPE Hub•Mar 21, 2011•Synageva, New Leaf Venture Partners, Yasuda Enterprise Development, The Stephens Group and 2 others
•
Ubiquisys secures $9M growth investmentMobile Europe•Jul 12, 2010•Ubiquisys, Yasuda Enterprise Development, Accel, Atlas Venture and 2 others
•
Ubiquisys Raises $9 Million - PE HubPE Hub•Jul 12, 2010•Ubiquisys, Yasuda Enterprise Development, Accel, Atlas Venture and 2 others
•
•
•
Kovio raises $20 million for chip-printing technology for tiniest radios and sensorsVentureBeat•Jul 13, 2009•Kovio, Bessemer Venture Partners, JVP, Panasonic Ventures and 10 others
•
ZettaCore's Molecular Technology Receives $21 Million Funding BoostNanowerk•May 10, 2009•ZettaCore, DFJ, Panasonic Ventures, Access Venture Partners and 11 others
